ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Michael Friedman to Retire as CEO of City of Hope

March 1, 2013

FCRC Recompetition To Be Split Into Two Major Contract, For Research And “Everything Else”

September 5, 1980

NCAB Asks For Cost Reimbursement n Patients In Clinical Trials Until More Data Available

October 5, 1984

Large Pregnancy Weight Gain Raises Risk For Breast Cancer

May 31, 2002

Cancer Registry Says Paper By Jon Sudbo Was Based On Fabricated Data.

January 27, 2006

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

June 1, 2001